Department of Ophthalmology, King Chulalongkorn Memorial hospital
Bangkok, 10330, Thailand
NCT Number: NCT00457223
The purpose of this study is to compared between conventional pterygium excision and AMT transplantation with suture and with fibrin glue.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 2 / Phase 3
Bangkok, 10330, Thailand
There are few studies about use of fibrin glue in pterygium surgery with conjunctival auto-graft with promising outcome. Less recurrent rate, less discomfort and halve surgical time were reported.
Up to our knowledge,there is no report of fibrin glue in pterygium excision with amniotic membrane transplantation(AMT). There is conventional technique to use AMT in King Chulalongkorn Memorial Hospital because some benefits over conjunctival auto-graft e.g.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After pterygium excision, amniotic membrane was shaped and attached to bare scleral area using fibrin glue (Quixil®) in 16 eyes of 16 patients of FG group and continuous suture with nylon 10-0 in 16 eyes of 16 patients of SU group.
Other names: Quixil®, Nylon 10-0
Time frame: during surgery and after surgery up to 30 days
Time frame: start and to the end of surgery
Time frame: until 30 days
Time frame: up to 30 days
Time frame: until last follow up
Chulalongkorn University
Other
Randomized Controlled Trial to Compare Fibrin Glue and Suture in Primary Pterygium Excision With Amniotic Membrane Transplantation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05794204
Conjunctival Diseases, Eye Diseases
Glendale, California, United States
View Trial DetailsNCT05978687
Conjunctival Diseases, Eye Diseases
Brussels, Brussels Capital, Belgium
View Trial DetailsNCT06944132
Conjunctival Diseases, Corneal Diseases
Cairo, Egypt
View Trial DetailsNCT05627947
Conjunctival Diseases, Eye Diseases
Shibīn al Kawm, Egypt
View Trial Details